Aziyo Biologics Inc reports results for the quarter ended in December - Earnings Summary

Elutia

03/03/2022 22:38

* Aziyo Biologics Inc  AZYO.OQ  reported a quarterly
adjusted loss
of 82 cents​​ per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 68 cents per share.
    * Revenue fell 12.9% to $10.86 million from a year ago; 
analysts
expected $11.06 million. 
    * Aziyo Biologics Inc's reported EPS for the quarter was a
loss
of 82 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Aziyo Biologics Inc shares had risen by 6.2% this quarter.
    * The company reported a quarterly loss of $9.06 million.
    * Wall Street's median 12-month price target for Aziyo
Biologics
Inc is $13.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 3 at 10:38 p.m.  ​All
figures in US dollars unless otherwise stated